ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.2301
-0.0299 (-11.50%)
At close: Mar 9, 2026
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $1.86 million as of March 10, 2026. Its market cap has decreased by -39.12% in one year.
Market Cap
1.86M
Enterprise Value
1.33M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.23
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from 95.47M to 1.86M, a decrease of -98.05%. That is a compound annual growth rate of -61.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.86M | 72.23% |
| Dec 31, 2025 | 1.08M | -59.32% |
| Dec 31, 2024 | 2.66M | -43.66% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
| Feb 10, 2022 | 95.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galera Therapeutics | 3.02M |
| ProtoKinetix | 2.73M |
| Clearside Biomedical | 2.62M |
| Sorrento Therapeutics | 2.61M |
| Enzolytics | 2.42M |
| VitaSpring Biomedical | 2.30M |
| LakeShore Biopharma | 2.27M |
| Vaccinex | 2.13M |